Overview

Oral Administration of Tranexamic Acid in Anterior Cruciate Ligament Surgery Reduce Postoperative Haemarthrosis

Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
0
Participant gender:
All
Summary
To find superiority relationship between oral and intravenous administration of tranexamic acid on peroperative and postoperative blood loss, haemarthrosis prevalence and improvement functional prognosis in anterior cruciate ligament arthroscopy.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Liege
Criteria
Inclusion Criteria:

- Primary arthroscopic surgery for anterior cruciate ligament reconstruction

Exclusion Criteria:

- Renal failure with serum creatinine level higher than 1,40 mg/dL

- Thromboembolic events in last 12 months before surgery

- Pregnancy

- Congenital or acquired coagulation diseases

- History of gastric surgery that could lead to malabsorption

- Diabetic gastro-paresis